MGRX
Mangoceuticals, Inc.
$0.39
+0.03 (+8.55%)
At close · Jul 14
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the 12 months from date of issuance of this filing.”View the 10-Q filed May 19, 2026
Market Cap
$6.72M
Shares
17,167,422
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$456.02K
-26%
FY2025
Net Income
-$20.64M
-137.1%
FY2025
Gross Margin
54.91%
-6.8pp
FY2025
Operating Margin
-3954.28%
-2659.9pp
FY2025
Diluted EPS
-$2.17
+54.8%
FY2025
Operating Cash Flow
-$5.85M
-20.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| $414.58K | $456.02K | $615.87K | $731.49K | $8939 | |
| $37.9K | $54.42K | $93.3K | $154.9K | $4089 | |
| $217.32K | $250.39K | $379.96K | $431.5K | $4850 | |
| — | 54.91% | 61.7% | 58.99% | 54.26% | |
| $3.27M | $3.76M | $3M | $3.32M | $1.64M | |
| — | $1.12M | $721.53K | — | — | |
| — | — | $9936 | $24.89K | — | |
| $16.8M | $18.28M | $8.35M | $9.65M | $2M | |
| -$16.58M | -$18.03M | -$7.97M | -$9.22M | -$1.99M | |
| — | -3954.28% | -1294.42% | -1260.28% | -22279.7% | |
| — | — | -$7.96M | -$9.19M | — | |
| — | $103.51K | $13.7K | -$6473 | $6473 | |
| -$2.62M | -$2.61M | -$735.23K | $6473 | -$6473 | |
| -$19.21M | -$20.64M | -$8.71M | -$9.21M | -$2M | |
| -$19.21M | -$20.64M | -$8.71M | -$9.21M | -$2M | |
| — | -4526.76% | -1413.63% | -1259.4% | -22352.11% | |
| -$354 | -$461 | -$1081 | — | — | |
| — | -$21.82M | -$9.51M | — | — | |
| -$19.22M | -$20.64M | -$8.72M | -$9.21M | — | |
| USD/shares | — | -$2.17 | -$4.80 | -$8.58 | -$2.85 |
| USD/shares | — | -$2.17 | -$4.80 | -$8.58 | -$2.85 |
| shares | — | 10.07M | 1.98M | 1.07M | 719.87K |
| shares | — | 10.07M | 1.98M | 1.07M | 719.87K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Health Information Services median 1.34×
EV/EBIT
—
Health Information Services median 25.06×
P/E (TTM)
—
Health Information Services median 33.12×